78 related articles for article (PubMed ID: 2873602)
1. Preliminary experiences and results with the Munich version of the Andreasen Scale. Assessment of productive and negative symptoms in chronic schizophrenic patients.
Dieterle DM; Albus MI; Eben E; Ackenheil M; Rockstroh W
Pharmacopsychiatry; 1986 May; 19(3):96-100. PubMed ID: 2873602
[TBL] [Abstract][Full Text] [Related]
2. Self-reports in chronic schizophrenic patients with primary negative symptoms: preliminary results.
Gerbaldo H; de las Carreras C; Osuna A; Laves GS; Orlando JC
Pharmacopsychiatry; 1990 Jul; 23(4):195-7. PubMed ID: 2381987
[TBL] [Abstract][Full Text] [Related]
3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
4. [Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients].
Bralet MC; Yon V; Loas G; Noisette C
Encephale; 2000; 26(6):32-41. PubMed ID: 11217537
[TBL] [Abstract][Full Text] [Related]
5. [Follow-up dynamics of schizophrenic diseases in adolescence].
Schulz E; Martin M; Remschmidt H
Z Kinder Jugendpsychiatr; 1994 Dec; 22(4):262-74. PubMed ID: 7856322
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Mini Mental State Examination and Brief Psychiatric Rating Scale on aged schizophrenic patients.
Seno H; Shibata M; Fujimoto A; Koga K; Kanno H; Ishino H
Psychiatry Clin Neurosci; 1998 Dec; 52(6):567-70. PubMed ID: 9895202
[TBL] [Abstract][Full Text] [Related]
7. Symptom dimensions and needs of care among patients with schizophrenia in hospital and the community.
Nakanishi M; Setoya Y; Kodaka M; Makino H; Nishimura A; Yamauchi K; Mimura M; Sato H; Arata H; Yukumi H; Amagasa T; Ueno H; Miyamoto Y; Sugie T; Anzai N
Psychiatry Clin Neurosci; 2007 Oct; 61(5):495-501. PubMed ID: 17875027
[TBL] [Abstract][Full Text] [Related]
8. [The frequency of occurrence of negative symptoms at the early stage of schizophrenic psychosis].
Anczewska M
Psychiatr Pol; 1996; 30(1):31-41. PubMed ID: 8722237
[TBL] [Abstract][Full Text] [Related]
9. Response of negative symptoms of schizophrenia to neuroleptic treatment.
Serban G; Siegel S; Gaffney M
J Clin Psychiatry; 1992 Jul; 53(7):229-34. PubMed ID: 1639741
[TBL] [Abstract][Full Text] [Related]
10. Zotepine in the treatment of negative symptoms in chronic schizophrenia.
Fleischhacker WW; Barnas C; Stuppäck C; Unterweger B; Hinterhuber H
Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):58-60. PubMed ID: 2883684
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of standardized psychometric scales (BPRS, HDS)in the evaluation of schizophrenic symptoms (preliminary report)].
Linka M; Rybakowski J
Psychiatr Pol; 1990; 24(1):15-22. PubMed ID: 2284354
[TBL] [Abstract][Full Text] [Related]
12. [Negative schizophrenic symptoms and their detection].
Kukla F; Gold R
Fortschr Neurol Psychiatr; 1991 Feb; 59(2):60-6. PubMed ID: 2026379
[TBL] [Abstract][Full Text] [Related]
13. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
Loas G; Noisette C; Legrand A; Delahousse J
Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
[TBL] [Abstract][Full Text] [Related]
14. [The Short-Form impairment index (SFII) in schizophrenic patients].
Cuesta MJ; Pelegrín C; Peralta V; Juan JA; Villaverde A; Fernández MD
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1993; 21(1):5-8. PubMed ID: 8475820
[TBL] [Abstract][Full Text] [Related]
15. [Insight in schizophrenia: assessment of 31 patients with different scales].
Travers D; Levoyer D; Millet B
Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
[TBL] [Abstract][Full Text] [Related]
16. Does catatonia influence the phenomenology of childhood onset schizophrenia beyond motor symptoms?
Bonnot O; Tanguy ML; Consoli A; Cornic F; Graindorge C; Laurent C; Tordjman S; Cohen D
Psychiatry Res; 2008 Apr; 158(3):356-62. PubMed ID: 18272234
[TBL] [Abstract][Full Text] [Related]
17. Effect of maprotiline combined with conventional neuroleptics against negative symptoms of chronic schizophrenia.
Yamagami S; Soejima K
Drugs Exp Clin Res; 1989; 15(4):171-6. PubMed ID: 2570687
[TBL] [Abstract][Full Text] [Related]
18. Add-on mirtazapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine.
Delle Chiaie R; Salviati M; Fiorentini S; Biondi M
Exp Clin Psychopharmacol; 2007 Dec; 15(6):563-8. PubMed ID: 18179309
[TBL] [Abstract][Full Text] [Related]
19. The sensitivity of quality-of-life scale WHOQOL-100 to psychopathological measures in schizophrenia.
Orsel S; Akdemir A; Dağ I
Compr Psychiatry; 2004; 45(1):57-61. PubMed ID: 14671738
[TBL] [Abstract][Full Text] [Related]
20. [Inter-observer reliability of negative schizophrenic symptoms].
Peralta Martín V; Cuesta Zorita MJ; de León J
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1991; 19(4):221-5. PubMed ID: 1957714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
